N. K. Mamporia
N. K. Mamporia has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Mager
People’s Friendship University of Russia
1 shared publication - Nikolay V. Sturov
Peoples’ Friendship University of Russia named after Patrice Lumumba
1 shared publication - Sergey Vitalievich Popov
RUDN University
1 shared publication
Latest Publications
- Open Access
- 15 November 2020
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 92 (11) , 106-109
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Selective inhibitors of sodium-glucose cotransporter belong to a new class of drugs for the treatment of type 2 diabetes mellitus. The mechanism of their action is based on insulin-independent reduction of glucose reabsorption in the proximal renal tubules, which leads to stimulation of its excretion in the urine and, accordingly, to a decrease in the concentration of glucose in the blood plasma. Drugs of this group demonstrate effectiveness in the treatment of type 2 diabetes, but their use may be associated with an increased frequency of urinary tract infections. Pharmacological glucosuria, which leads to a decrease in the concentration of glucose in the blood, creates the preconditions for the occurrence of urinary tract infections. Urinary tract and genital infections are the most common adverse events associated with the use of sodium-glucose cotransporter inhibitors. In the presented literature review for 20162019, the relationship between urinary tract infections in patients with type 2 diabetes mellitus and therapy with sodium-glucose cotransporter inhibitors was analyzed.
- 15 November 2020
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 92 (11) , 106-109
Open AccessUrinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Selective inhibitors of sodium-glucose cotransporter belong to a new class of drugs for the treatment of type 2 diabetes mellitus. The mechanism of their action is based on insulin-independent reduction of glucose reabsorption in the proximal renal tubules, which leads to stimulation of its excretion in the urine and, accordingly, to a decrease in the concentration of glucose in the blood plasma. Drugs of this group demonstrate effectiveness in the treatment of type 2 diabetes, but their use may be associated with an increased frequency of urinary tract infections. Pharmacological glucosuria, which leads to a decrease in the concentration of glucose in the blood, creates the preconditions for the occurrence of urinary tract infections. Urinary tract and genital infections are the most common adverse events associated with the use of sodium-glucose cotransporter inhibitors. In the presented literature review for 20162019, the relationship between urinary tract infections in patients with type 2 diabetes mellitus and therapy with sodium-glucose cotransporter inhibitors was analyzed.